- Home
- EXEL vs QBTS Comparison
EXEL vs QBTS Comparison
Compare EXEL & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | QBTS |
|---|---|---|
| Founded | 1994 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.3B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | QBTS |
|---|---|---|
| Price | $44.47 | $25.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 15 |
| Target Price | ★ $45.45 | $32.80 |
| AVG Volume (30 Days) | 2.2M | ★ 38.5M |
| Earning Date | 02-10-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | $24,144,000.00 |
| Revenue This Year | $9.74 | $196.28 |
| Revenue Next Year | $12.27 | $51.47 |
| P/E Ratio | $18.63 | ★ N/A |
| Revenue Growth | 9.93 | ★ 156.20 |
| 52 Week Low | $31.90 | $4.45 |
| 52 Week High | $49.62 | $46.75 |
Technical Indicators
Market Signals| Indicator | EXEL | QBTS |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 43.65 |
| Support Level | $43.00 | $24.74 |
| Resistance Level | $45.41 | $31.36 |
| Average True Range (ATR) | 1.65 | 2.27 |
| MACD | -0.09 | -0.42 |
| Stochastic Oscillator | 58.22 | 10.09 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.